Anurag Singh MD

Hematologic Oncology

Associate Professor

University of Kansas Cancer Center2330 Shawnee Mission PkwyWestwood, KS 66205

Dr. Singh is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Singh's full profile Already have an account?

Education & Training

SUNY Upstate Medical UniversityFellowship, Hematology and Medical Oncology, 2010 - 2013
SUNY Upstate Medical UniversityResidency, Internal Medicine, 2007 - 2010
Maulana Azad Medical CollegeClass of 2006

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

KS State Medical License 2013 - 2027
MO State Medical License 2021 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
National Board of Physicians and Surgeons Hematology
National Board of Physicians and Surgeons Internal Medicine
National Board of Physicians and Surgeons Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017

Clinical Trials

Mitopure™ (Proprietary Urolithin A) Bioavailability in Healthy Adults Start of enrollment: 2019 Nov 08
COMPLETED
NA

Publications & Presentations

PubMed

Outcomes of Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis in Acute Myeloid Leukemia and Myelodysplastic Syndromes Pat...
Muhammad Umair Mushtaq, Muhammad Kashif Amin, Amir Kasaeian, Shajadi Patan, Aqeeb Ur Rehman
Clinical Lymphoma, Myeloma & Leukemia. 2026-07-01
Delayed fatal neurotoxicity in post CAR-T cell therapy for multiple myeloma, a case report.
Hamza Khoudari, Abdalla Shoaib, Muhammad Nashatizadeh, Nausheen Ahmed, Forat Lutfi
Leukemia Research Reports. 2026-01-01
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Older Patients Aged 65 Years and Above With Myelofibrosis.
Moazzam Shahzad, Muhammad Kashif Amin, Sohaib Irfan, Rania Ahsan, Hana Qasim
Clinical Lymphoma, Myeloma & Leukemia. 2026-01-01

Abstracts/Posters

In-Hospital Morbidity and Mortality Among Acute Myeloid Leukemia Patients Admitted for Hematopoeitic Stem Cell Transplants between 2002-2014
Anurag K. Singh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Outcome of Autologous Stem Cell Transplantation Following PD-(L)1 Based Salvage Therapy for Multiply Relapsed Patients with Classic Hodgkin Lymphoma
Anurag K. Singh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplant after Programmed Cell Death 1 (PD-1) / Programmed Cell Death Ligand 1 (PD-L1) Blockade for Classic...
Anurag K. Singh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

Aspirin May Increase Survival Time for Patients with Head/Neck, Lung CancersSeptember 26th, 2019
Can Aspirin Help Tackle Some Cancers?September 23rd, 2019
Taking Baby Aspirin Improves Overall Survival for Patients with Head & Neck, Lung CancerSeptember 19th, 2019